Company Name or Ticker Symbol
Search for other Categories

Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

NBS's Net Income Year on Year Growth by Quarter and Year

Caladrius Biosciences,'s Net Income results by quarter and year

Select the Comparisons : Select the Ratio:                        
NBS Net Income (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December -6.09 -33.23 -11.69 -12.72
III Quarter September -7.29 -11.39 -17.18 -9.28
II Quarter June -7.88 -17.16 -12.77 -8.63
I Quarter March -12.05 -19.23 -13.83 -8.86
FY   -33.31 -81.01 -55.47 -39.49

Financial Statements
Caladrius Biosciences,'s forth quarter 2016 Net Income $ -6.09 millions NBS's Income Statement
Caladrius Biosciences,'s forth quarter 2015 Net Income $ -33.23 millions Quarterly NBS's Income Statement
NBS's Growth by Division See NBS's Growth by Segment

NBS Net Income ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

NBS Net Income Growth Comment
Caladrius Biosciences, Inc. in the forth quarter recorded net loss of $ -6.09 millions.

According to the results reported in the forth quarter, Caladrius Biosciences, Inc. achieved the best Net Income growth in Biotechnology & Drugs industry. While Caladrius Biosciences, Inc.' s Net Income no change of % ranks overall at the positon no. 0 in the forth quarter.

Net Income Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
S&P 500 #0
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %

You need to upgrade your Flash Player

Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
NBS's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for NBS's Competitors
Net Income Growth for Caladrius Biosciences,'s Suppliers
Net Income Growth for NBS's Customers

You may also want to know
NBS's Annual Growth Rates NBS's Profitability Ratios NBS's Asset Turnover Ratio NBS's Dividend Growth
NBS's Roe NBS's Valuation Ratios NBS's Financial Strength Ratios NBS's Dividend Payout Ratio
NBS's Roa NBS's Inventory Turnover Ratio NBS's Growth Rates NBS's Dividend Comparisons

Companies with similar Net Income no change for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2016
Petmed Express Inc -1.37 %$ -1.370 millions
Stryker Corp -2.30 %$ -2.299 millions
Align Technology Inc -2.57 %$ -2.570 millions
Universal Health Services Inc -6.57 %$ -6.575 millions
Atrion Corp -7.90 %$ -7.901 millions
Abbvie Inc. -8.31 %$ -8.306 millions
Surmodics Inc -8.48 %$ -8.476 millions
Amedisys Inc -8.98 %$ -8.981 millions
Abaxis Inc -14.00 %$ -13.998 millions
Conmed Corp -14.57 %$ -14.570 millions
Resmed Inc -15.22 %$ -15.217 millions
Utah Medical Products Inc -15.38 %$ -15.385 millions
Owens & Minor Inc -15.47 %$ -15.474 millions
Mednax, Inc. -15.51 %$ -15.512 millions
Lifepoint Health, Inc. -15.88 %$ -15.884 millions
Quest Diagnostics Inc -16.50 %$ -16.500 millions
Biogen Inc. -21.82 %$ -21.818 millions
Pacific Health Care Organization Inc -22.63 %$ -22.626 millions
Anika Therapeutics, Inc. -26.79 %$ -26.786 millions
Halyard Health, Inc. -31.03 %$ -31.034 millions
Applied Genetic Technologies Corp -31.66 %$ -31.658 millions
Vca Inc. -33.79 %$ -33.791 millions
Lannett Co Inc -39.54 %$ -39.542 millions
Teleflex Incorporated -39.71 %$ -39.710 millions
Ikang Healthcare Group, Inc. -39.82 %$ -39.816 millions
Ophthalix, Inc. -42.62 %$ -42.618 millions
Catalent, Inc. -43.14 %$ -43.137 millions
Parexel International Corp -44.67 %$ -44.670 millions
Sciclone Pharmaceuticals Inc -48.89 %$ -48.892 millions
Pdl Biopharma, Inc. -50.53 %$ -50.529 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
SILC's Profile
Stock Price
SILC's Financials
SILC's Expectations
Business Description
Charts & Quotes
SILC's News
SILC's Competitors
Customers & Markets
Economic Indicators
SILC's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com